文献速递垂体与肾上腺疾病

糖皮质激素过量经正反馈机制触发ACTH依赖性周期性库欣综合征

ACTH-Dependent Cyclic Cushing Syndrome Triggered by Glucocorticoid Excess Through a Positive-Feedback Mechanism.
PubMed 文献 · J Clin Endocrinol Metab · 2019-01-01

本文报告一例75岁女性ACTH依赖性周期性库欣综合征,4年内出现6次ACTH与皮质醇升高周期。在第六次高皮质醇期缓解后,患者服用25 mg氢化可的松4周并出现ACTH依赖性高皮质醇血症,随后1 mg地塞米松治疗2周使ACTH与皮质醇逐渐升高,诱发第八次高皮质醇期。地塞米松与美替拉酮联用未升高ACTH与皮质醇,并成功阻止ACTH依赖性高皮质醇血症的发生。

要点

  • 外源性糖皮质激素可能通过正反馈环路触发ACTH依赖性周期性库欣综合征的高皮质醇期。
  • 地塞米松与美替拉酮联用可阻止该患者ACTH依赖性高皮质醇血症的发生。

核心结论

  • 外源性糖皮质激素可能经糖皮质激素正反馈环路触发ACTH依赖性周期性库欣综合征的高皮质醇期,内源性糖皮质激素合成可能参与其周期性。

研究设计与样本

  • 单个病例报告:一例75岁女性ACTH依赖性周期性库欣综合征,既往4年内出现6次ACTH与皮质醇升高周期。

主要发现

  • 高皮质醇期低剂量及大剂量地塞米松均不能抑制血浆ACTH与皮质醇水平。
  • 每日美替拉酮治疗在每个高皮质醇期均降低血浆皮质醇与ACTH水平。
  • 第六次高皮质醇期缓解后服用25 mg氢化可的松4周,出现ACTH依赖性高皮质醇血症。
  • 1 mg地塞米松治疗2周使血浆ACTH与皮质醇逐渐升高,导致第八次高皮质醇期。
  • 地塞米松与美替拉酮联用未升高血浆ACTH或皮质醇,并成功预防ACTH依赖性高皮质醇血症。

临床怎么用

  • 对周期性库欣综合征患者使用外源性糖皮质激素需警惕诱发高皮质醇期。
  • 地塞米松与美替拉酮联用可能用于预防此类ACTH依赖性高皮质醇血症。

局限性

  • 为单个病例报告,结论的普遍适用性有限。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

CONTEXT: Cyclic Cushing syndrome is a rare variant of Cushing syndrome that demonstrates periodic cortisol excess. It has been thought that inhibition of a glucocorticoid positive-feedback loop is associated with remission of hypercortisolism in ACTH-dependent cyclic Cushing syndrome. However, the underlying mechanism that triggers the development of the hypercortisolism is still unknown. We observed a case of ACTH-dependent cyclic Cushing syndrome that was developed by exogenous glucocorticoids, possibly through a glucocorticoid positive-feedback loop. CASE DESCRIPTION: A 75-year-old woman had experienced cyclic ACTH and cortisol elevations six times in the previous 4 years. Her diagnosis was cyclic Cushing syndrome. During the hypercortisolemic phase, neither low-dose nor high-dose dexamethasone suppressed her plasma ACTH and cortisol levels. Daily metyrapone therapy decreased her plasma cortisol and ACTH levels during every hypercortisolemic phase. After the sixth remission of a hypercortisolemic phase, she took 25 mg of hydrocortisone for 4 weeks and developed ACTH-dependent hypercortisolemia. Treatment with 1 mg of dexamethasone gradually increased both plasma ACTH and cortisol levels over 2 weeks, resulting in the eighth hypercortisolemic phase. Treatment using a combination of dexamethasone and metyrapone did not increase plasma ACTH or cortisol level and successfully prevented development of ACTH-dependent hypercortisolism. CONCLUSION: We present an interesting case of cyclic Cushing syndrome in which ACTH-dependent hypercortisolemic phases relapsed during exogenous glucocorticoid treatment. A glucocorticoid positive-feedback loop and endogenous glucocorticoid synthesis may play key roles in the periodicity of hypercortisolism in cyclic Cushing syndrome.

来源:J Clin Endocrinol Metab,查看原文。版权归原作者所有。

引用

  1. Seki Y, Morimoto S, Saito F, et al. ACTH-Dependent Cyclic Cushing Syndrome Triggered by Glucocorticoid Excess Through a Positive-Feedback Mechanism. J Clin Endocrinol Metab. 2019. PMID: 30561712. doi:10.1210/jc.2018-02268

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。